BRCA1 and cancer: Variants in BRCA1/2 are categorized into the following groups: pathogenic alleles that either inactivate the protein or are documented to confer risk for cancer, variants of unknown significance (VUS) that are as yet unclassified, likely benign and benign variants that are not known to confer cancer risk.